Causes of Elevated Bilirubin in Pregnancy
Elevated bilirubin in pregnancy is most commonly caused by gallstones (25%) and preeclampsia-related disorders including HELLP syndrome (24%), followed by intrahepatic cholestasis of pregnancy (ICP) (13%), with viral hepatitis no longer being a frequent cause in the United States. 1
Primary Etiologies (in Order of Frequency)
1. Gallstone Disease (25%)
- Most common cause of hyperbilirubinemia in contemporary pregnant populations
- Represents a dramatic shift from historical data when viral hepatitis predominated
- Requires consideration of cholecystectomy, which can be safely performed in any trimester 2
2. Preeclampsia/Eclampsia/HELLP Syndrome (24%)
- Second most common cause
- HELLP syndrome specifically involves hemolysis, elevated liver enzymes, and low platelets
- These conditions require planning for delivery and timely evaluation for possible liver transplantation 2
- Daily aspirin prophylaxis should begin at week 12 of gestation for at-risk patients 2
3. Intrahepatic Cholestasis of Pregnancy (13%)
- Presents with pruritus in second/third trimester
- Bilirubin typically remains <6 mg/dL in ICP 2
- If bilirubin is markedly or persistently elevated in suspected ICP, investigate alternative causes 3
- Diagnosed by serum bile acids >10 μmol/L with pruritus 2
4. Acute Fatty Liver of Pregnancy (AFLP)
- Less common but life-threatening
- Requires urgent delivery and intensive supportive care 4
- May necessitate liver transplantation evaluation 2
5. Hyperemesis Gravidarum (5%)
- Typically causes mild transaminase and bilirubin elevation
- Managed supportively with nutritional intervention 4
6. Viral Hepatitis (6%)
- No longer a common cause in the United States due to vaccination programs and demographic shifts 1
- Still requires exclusion, particularly hepatitis C 3
7. Other Causes to Exclude
- Extrahepatic biliary obstruction (ultrasound evaluation) 3
- Autoimmune hepatitis (check AMA, ANA, SMA) 3
- Pre-existing chronic liver disease 3
- Sepsis 5
- Genetic disorders (e.g., UGT1A1 polymorphisms, Crigler-Najjar syndrome) 6, 7
Critical Clinical Pitfalls
When evaluating elevated bilirubin in pregnancy, the level of bilirubin elevation provides diagnostic clues:
- Bilirubin >6 mg/dL is unusual for ICP alone and should prompt investigation for alternative or concurrent diagnoses 2
- Marked hyperbilirubinemia may indicate AFLP, HELLP syndrome, or underlying genetic disorders 6
Maternal hyperbilirubinemia carries significant fetal risk:
- Increased stillbirths, fetal malformations, neonatal deaths, and small-for-gestational-age births 1
- Maternal bilirubin levels predict both maternal and fetal adverse outcomes 5
Diagnostic Approach
When confronted with elevated bilirubin in pregnancy:
- Assess timing and symptoms: Pruritus suggests ICP; hypertension/proteinuria suggests preeclampsia spectrum
- Measure serum bile acids: Essential for ICP diagnosis (>10 μmol/L diagnostic) 2
- Check complete liver panel: ALT, AST, alkaline phosphatase, GGT 3
- Evaluate for preeclampsia: Blood pressure, proteinuria, platelet count 3
- Ultrasound abdomen: Rule out biliary obstruction 3
- Serologic testing: HCV, autoimmune markers if indicated 3
The combination of ALT, bilirubin, GGT, and alkaline phosphatase can generate a laboratory score that reliably predicts adverse outcomes 3